Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: Implications for the treatment of radiation-induced haemorrhagic cystitis

BJU International

Volumn 94, Issue 9, 2004, Pages 1275-1278

  Kian, Tai Chong ^a,c   Hampson, Neil B ^b   Bostwick, David G ^d   Vessella, Robert L ^e   Corman, John M ^a,b  

^a Sect of Urol and Ren Transplant   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d BOSTWICK LABORATORIES   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Haemorrhagic cystitis; Hyperbaric oxygen; Prostate cancer radiotherapy

Indexed keywords

KI 67 ANTIGEN; PROTEIN P27; PROTEIN P53; RACEMASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CONTROLLED STUDY; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HYPERBARIC OXYGEN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NECROSIS; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; RANK SUM TEST; STAINING; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CYSTITIS; HEMORRHAGE; HYPERBARIC OXYGENATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; PROSTATIC NEOPLASMS; RADIATION INJURIES; URINARY BLADDER;

EID: 11144221435     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05156.x     Document Type: Article

References (20)

1. Crew JP, Jephcott CR, Reynard JM. Radiation-induced haemorrhagic cystitis. Eur Urol 2001; 40: 111-23
2. Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169: 2200-2
3. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for hemorrhagic radiation cystitis. Lancet 1995; 346: 803-5
4. Mayer R, Klemen H, Quehenberger F et al. Hyperbaric oxygen - an effective tool to treat radiation morbidity in prostate cancer. Radiother Oncol 2001; 61: 151-6
5. Cerutti PA. Pro-oxidant states and tumor promotion. Science 1985; 227: 375-81
6. Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen. Does it promote growth or recurrence of malignancy? Undersea Hyperb Med 2003; 30: 1-18
7. Offersen BV, Borre M, Sorensen FB, Overgaard J. Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis. APMIS 2002; 110: 177-85
8. Rubin MA, Zhou M, Dhanasekaran SM et al. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287: 1662-70
9. Claudio PP, Zamparelli A, Garcia FU et al. Expression of cell-cycle-regulated proteins pRb2/p130, 107, 27 (kip1), 53, mdm-2, and Ki-67 (MIB-1) in prostate gland adenocarcinoma. Clin Cancer Res 2002; 8: 1808-15
10. Yang RM, Naitoh J, Murphy M et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 1998; 159: 941-5
11. Feldmeier JJ. Hyperbaric oxygen 2003. Indications and Results. The Hyperbaric Oxygen Therapy Committee report. Undersea and Hyperbaric Medical Society. Kensington, Maryland, 2003: 1-4
12. Robertson PW, Hart BB. Assessment of tissue oxygenation. Resp Care Clin N Am 1999; 5: 221-63
13. O'Reilly KJ, Hampson NB, Corman JM. Hyperbaric oxygen in urology. AUA Update Series 2002; Vol. XXI: Lesson 4
14. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160: 519-24
15. Shoshani O, Shupak A, Ullmann Y et al. The effect of hyperbaric oxygenation on the viability of human fat injected into nude mice. Plas Reconstr Surg 2000; 106: 1390-6
16. Thorn JJ, Kallehave F, Westergaard P, Hansen EH, Gottrup F. The effect of hyperbaric oxygen on irradiated oral tissues: transmucosal oxygen tension measurements. J Oral Maxillofac Surg 1997; 55: 1103-7
17. Kalns JE, Piepmeier EH. Exposure to hyperbaric oxygen induces cell cycle perturbation in prostate cancer cells. In Vitro Cell Dev Biol Anim 1999; 35: 98-101
18. Movsas B, Chapman JD, Greenberg RE et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age-an Eppendorf p02 study. Cancer 2000; 89: 2018-24
19. Kalns J, Krock L, Piepmeier E Jr. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 1998; 18: 363-7
20. Osorio-Acosta V, Gomez-Sampera A, Castellanos-Gutierrez R et al. Estrogenos y oxigenacion hiperbarica en el tratamiento del cancer de prostata en etapas avanzadas. Informe preliminary. Gaceta Med 1990; 1: 88-92